Cargando…

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?

Detalles Bibliográficos
Autores principales:	Tang, Patrick Chun Hean, Ng, Wern Hann, King, Nicholas J. C., Mahalingam, Suresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491521/ https://www.ncbi.nlm.nih.gov/pubmed/36129963 http://dx.doi.org/10.1371/journal.ppat.1010821

Ejemplares similares

Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020)

TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease
por: Liu, Xiang, et al.
Publicado: (2022)

The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan
por: Liu, Xiang, et al.
Publicado: (2022)

Does reduced smoking if you can’t stop make any difference?
por: Begh, Rachna, et al.
Publicado: (2015)

Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
por: Ng, Wern Hann, et al.
Publicado: (2021)

The importance of naturally attenuated SARS‐CoV‐2in the fight against COVID‐19
por: Armengaud, Jean, et al.
Publicado: (2020)

Stop Discussing New Medical Specialty Boards
por: Choung, Ji Tae
Publicado: (2018)

When it comes to stopping tuberculosis, what is actually “missing”?
por: Fatah, Farahdiba Zalika, et al.
Publicado: (2022)

What Is Stopping the Use of Genetically Modified Insects for Disease Control?
por: Panjwani, Anusha, et al.
Publicado: (2016)

The challenge of clinical adoption—the insurmountable obstacle that will stop machine learning?
por: Taylor, Jonathan, et al.
Publicado: (2018)

Role of MXRA8 in Ross River Virus Disease Pathogenesis
por: Ng, Wern Hann, et al.
Publicado: (2023)

Genome Plasticity of African Swine Fever Virus: Implications for Diagnostics and Live-Attenuated Vaccines
por: Faburay, Bonto
Publicado: (2022)

Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
por: Czajka, Timothy F., et al.
Publicado: (2021)

Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak
por: Chakraborty, Chiranjib, et al.
Publicado: (2020)

Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes
por: Willschke, Harald, et al.
Publicado: (2021)

Critical View on the Importance of Host Defense Strategies on Virus Distribution of Bee Viruses: What Can We Learn from SARS-CoV-2 Variants?
por: Piot, Niels, et al.
Publicado: (2022)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
por: Crawford, Emily D., et al.
Publicado: (2020)

Nano-targeting lessons from the SARS-CoV-2
por: Ribeiro, I.R.S., et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Can Prophylactic High Flow of Humidified and Warmed Filtered Air Improve Survival from Bacterial Pneumonia and SARS-CoV-2 in Elderly Individuals? The Role of Surfactant Protein A
por: Abbasi, Ata, et al.
Publicado: (2021)

Potential Applications of Plant Biotechnology against SARS-CoV-2
por: Capell, Teresa, et al.
Publicado: (2020)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?
por: Tournier, Jean-Nicolas, et al.
Publicado: (2021)

Are Older People Really More Susceptible to SARS-CoV-2?
por: Zhang, Shuo, et al.
Publicado: (2022)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

Opinion: To assess marine cloud brightening's technical feasibility, we need to know what to study—and when to stop
por: Diamond, Michael S., et al.
Publicado: (2022)

Occupational health responses to COVID‐19: What lessons can we learn from SARS?
por: Koh, David, et al.
Publicado: (2020)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

SARS-CoV-2: Cross-scale Insights from Ecology and Evolution
por: Snedden, Celine E., et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_el452ngn35hafpq3vnmk8t8vm7